Get started
AUROBINDO PHARMA LTD.AUROBINDO PHARMA LTD.AUROBINDO PHARMA LTD.

AUROBINDO PHARMA LTD.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

AUROPHARMA trade ideas

Amazing breakout on Weekly / Daily Timeframe - AUROPHARMACheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favour that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPEECTED! NOTE for learners: Place the breakout levels as per the chart shared and track it yourself to get amazed!! #No complicated chart patterns #No big big indicators #No Excel sheet or number magics TRADE IDEA: WAIT FOR THE STOCK TO BREAKOUT IN LOWER TIMEFRAME AND RETRACE IF NEEDED. SL IS NEARER SUPPORT ZONE IN 1HR TIMEFRAME.
NSE:AUROPHARMALong
by Yoyohoneysingh93
Auro Pharma - Time to exit It is in the distribution zone and gradually coming down. Sell below high of 14th December 2023. Those who are still long in the stock may get into trap. Don't be greedy at all. If sitting in profits, exit immediately and trade in the next month only. Disclaimer: I am not a SEBI Registered Analyst. Please consult your financial advisor before making any decision. I will not be responsible for any of your profits/losses. This is only for educational purposes. Let you grow. May! I follow you.
NSE:AUROPHARMA
by rekhi567
2
Flag & Pole Pattern_Breakout_Retest Successfully Here's how the flag and pole pattern typically forms: #Pole Formation: Upward or Downward Move: The pattern begins with a strong and sharp price movement, either upward or downward. This initial move is referred to as the "pole" and represents a significant and rapid change in market sentiment. #Flag Formation: Consolidation: Following the pole, there is a period of consolidation where prices move in a horizontal or slightly counter-trend direction. This consolidation forms a rectangular-shaped pattern known as the "flag." During this phase, trading volume often contracts. #Breakout: Continuation: The pattern concludes with a breakout in the direction of the initial pole. If the pole was upward, the breakout is typically to the upside, and if the pole was downward, the breakout is typically to the downside. #Volume Consideration: Volume Analysis: Traders often analyze the volume during the formation of the flag and the subsequent breakout. Generally, a breakout with higher volume is considered more significant and is thought to confirm the validity of the pattern. #Target Projection: Measuring Move: Traders may use the height of the pole to project a target for the ensuing price move. This involves measuring the distance from the beginning of the pole to the high or low point of the flag and then extending that distance from the breakout point.
NSE:AUROPHARMALong
by Pranay_Kamdi
1
AUROBINDO PHARMA looks like its going to blastAuropharma is making an inverse head and shoulder pattern at a resistance level, now this is not a reversal pattern, it is a bullish continuation pattern which forms during an ongoing trend. The only point of concern is that the pattern is being formed at a resistance level of weekly timeframe. Weekly levels hold more weightage than any short period timeframes. If you love to risk then go ahead otherwise if you are a confluence trader like me, you can skip it. If the breakout comes real, this will hopefully touch all time highs. If i had to enter this, i will wait for a retest
NSE:AUROPHARMALong
by crocodile_trader
Aurobindo Pharma. Please refer to the notes mentioned on the chart. Also: (a) Candle of 9:16 a.m. in the last working day created resistance for the stock. (b). It also broke level of 11:27 candle of the day before yesterday candle. (c) for tomorrow 12-4-23 12:37 PM is the important candle. (d). On First December price made a high then fell below the level of 22nd and 23rd November 2023, after making continuous highs from February 2023. Conclusion: Sell on rise during this month unless, high of 1st December 2023 is broken. When, it breaks the low of 29th November 2023, expect more fall. Don't get into any trap. Its a sure sell, let the levels come. Disclaimer: I am not a SEBI Registered Analyst. Please consult your financial advisor before making any decision. I will not be responsible for any of your profits/losses. This is only for educational purposes. Let you grow. May! I follow you.
NSE:AUROPHARMA
by rekhi567
Aurobindo Pharma 1. Aurobindo Pharma showing its major resistance at the level of 1057.95 marked by white horizontal white line and second resistance 1041.55 marked by a green horizontal line. 2. As per William's R% it is in overbought zone. 3. Expected range as per option chart is 1050-990 with max pain at 990. 4. Today's two candles in the Indian Market are important (i) 12-1-23 9:16 AM and ((ii) 12-1-23 1:42 PM are important. All major stock especially Auto Stocks may show a dip for the month. Disclaimer: I am not a SEBI Registered Analyst. Please consult your financial advisor before making any decision. I will not be responsible for any of your profits/losses. This is only for educational purposes. Let you grow. May! I follow you.
NSE:AUROPHARMA
by rekhi567
Auropharma : Riding the Wave: StockJumps from 397 to 1000 October 13, 2020: Identified a B-Wave shift in Auropharma (TradingView Idea Published as mentioned below), predicting a decline from highs of 1065 to lows of 397- was looking for Wave -C Downside. These are complex corrections so I changed them to X-wave (instead of B-Wave) January 30, 2023: Noted that Auropharma was close to completing an Ending Diagonal, which eventually ended the fall at the lows of 397. Ending Diagonal as per New School Analysis or Wedges as per Old School or Traditional Analysis are classical patterns which suggest that the structure is about to end & sooner or later opposite side move will start. This is the reason, why I picked this stock as portfolio stock for 1000+ as the ending diagonal started from the highs of 1065 which was most likely to get retraced 100%. February 27, 2023: Published an idea on TradingView suggesting Auropharma was preparing for a rise to 1000 as stock made a low of 397 & started rising. A classical example of V-Shaped Recovery on Monthly Chart using wave analysis. November 18, 2023 (Today): Auropharma achieved the target, touching over 1000+, just a few points shy of the previous high of 1065. This journey of Auropharma's stock is a real-world example of wave analysis in action and will be featured...story continues Regards, WaveTalks
NSE:AUROPHARMA
by WaveTalks
4
Auropharma: A Must-Own Stock for 2024?Detailed technical analysis of Auropharma (NSE: AUROPHARMA) based on hourly timeframe. Technical Indicators RSI: The Relative Strength Index (RSI) is currently at 62.5, indicating that the stock is overbought. However, the RSI is still below the 70 level, which is considered to be overbought territory. This suggests that the stock may continue to rise in the short term. MACD: The Moving Average Convergence Divergence (MACD) indicator is currently bullish, with the MACD line above the signal line and the histogram bars above zero. This suggests that the stock is likely to continue to move higher. OBV: The On Balance Volume (OBV) indicator is also bullish, with the OBV line trending upwards. This suggests that there is strong buying pressure behind the stock. Support And Resistance Levels. Support: The nearest support level is at ₹985. This is the level where the stock bounced off in October 2023. Resistance: The nearest resistance level is at ₹1015. This is the level where the stock has been rejected for the past few week. TRADE ENTRIES Long Entry: Traders could enter a long trade at the current level of ₹1002 to 1004 with a stop-loss order at ₹980 and a profit target of ₹1050,₹1100. Overall Outlook. Auropharma is currently in a bullish trend. The stock has broken out of a consolidation pattern and is now trading above its moving averages. The technical indicators are also bullish. However, the stock is overbought, so there is a risk of a pullback in the short term. Traders should be aware of this risk and use stop-loss orders to protect their capital. News • Auropharma receives FDA approval for generic version of blockbuster heartburn drug Prilosec. The approval is a major boost for Auropharma, as Prilosec is one of the top-selling drugs in the world. The generic version of the drug is expected to hit the market in 2024. • Auropharma enters into a joint venture with a Chinese company to develop and manufacture new drugs for the Chinese market. The joint venture is a strategic move by Auropharma to expand its presence in the Chinese market, which is the second-largest pharmaceutical market in the world • Auropharma announces a new research and development facility in India. The new facility will focus on developing new drugs for the Indian market. This investment is a sign of Auropharma's commitment to the Indian market, which is one of the fastest-growing pharmaceutical markets in the world. Fundamental Analysis • Auropharma is a leading generic drugs company with a strong track record of profitability and growth. The company has a diversified product portfolio and a strong presence in both emerging and developed markets. • Auropharma has a strong pipeline of new drugs in development. The company is investing heavily in research and development, which is expected to drive future growth. • Auropharma has a strong balance sheet and is well-positioned for future growth. The company has a low debt-to-equity ratio and a strong cash flow position. FINAL THOUGHTS 🪙😇 Auropharma is a well-positioned company with a strong track record of profitability and growth. The company is well-positioned to benefit from the growing global demand for generic drugs. The company's recent news announcements are also positive, and they suggest that Auropharma is well-positioned for future growth.
NSE:AUROPHARMALong
by ManojBakale
Add to Watchlist--consolidating after the long bull run --flag pattern formation --keep in Radar --Enter after the breakout with good volume Disclaimer: - The view expressed here is my personal view - Any decision you take, you need to take responsibility for the same - It's your hard earned money. Treat it wisely - Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance -- Do your own analysis and consult your financial adviser if need be
NSE:AUROPHARMALong
by shreks14